Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis

Ann Rheum Dis. 2005 Oct;64(10):1515. doi: 10.1136/ard.2005.043240.
No abstract available

Publication types

  • News
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cyclophosphamide / therapeutic use
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Randomized Controlled Trials as Topic
  • Scleroderma, Systemic / therapy*

Substances

  • Immunosuppressive Agents
  • Cyclophosphamide